Market Cap

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA Market Capitalization:

€69.0 Million

EUR as of Jan. 1, 2024

US$76.2 Million

business BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA Company Profile

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA Main Stock Listing

FSX: 6NQ

Market Capitalization History of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA market cap

Date Market Cap YoY Change
Jan. 1, 2024 €69.0 M -15.54%
Jan. 1, 2023 €81.7 M 39.36%
Jan. 1, 2022 €58.6 M -56.22%
Jan. 1, 2021 €133.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA Categories

Poland languages Healthcare languages Biotechnology
Poland Healthcare Poland Biotechnology

Stocks & Indices

BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek SA has the following listings and related stock indices.


Stock: FSX: 6NQ

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.